Edmond De Rothschild Holding S.A. Gamida Cell Ltd. Transaction History

Edmond De Rothschild Holding S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$5.85 - $8.33 $33,637 - $47,897	-5,750 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$3.93 - $4.59 $7,781 - $9,088	-1,980 Reduced 25.61%	5,750 $24,000
Q2 2020 Aug 07, 2020	SELL	$2.79 - $6.5 $19,530 - $45,500	-7,000 Reduced 47.52%	7,730 $35,000
Q3 2019 Nov 14, 2019	BUY	$3.0 - $5.09 $10,290 - $17,458	3,430 Added 30.35%	14,730 $61,000
Q2 2019 Aug 14, 2019	BUY	$4.98 - $11.32 $33,117 - $75,278	6,650 Added 143.01%	11,300 $57,000
Q1 2019 May 13, 2019	BUY	$9.8 - $14.38 $45,570 - $66,867	4,650 New	4,650 $53,000

31.4K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.